Level Four Advisory Services’s ChemoCentryx, Inc. CCXI Stock Holding History

Level Four Advisory Services’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,016	Closed	-$326K	–	675
2022 Q1	$326K	Buy	13,016 +1,276	+11%	+$35.9K	0.03%	496
2021 Q4	$427K	Buy	+11,740	New	+$412K	0.03%	440

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Level Four Advisory Services's CCXI Position: Q2 2022 in Review

Level Four Advisory Services sold out of ChemoCentryx, Inc. (CCXI) in Q2 2022, closing a stake of 13,016 shares — an estimated $326K sold.

Level Four Advisory Services first reported a position in CCXI in Q4 2021 and held it in 2 quarters. The position peaked at $427K in Q4 2021. 182 funds tracked by Wall St. Rank hold CCXI as of Q2 2022.

Level Four Advisory Services reported no remaining ChemoCentryx, Inc. position as of Q2 2022 after selling out during the quarter.
Level Four Advisory Services sold 13,016 ChemoCentryx, Inc. shares in Q2 2022, an estimated $326K.
Level Four Advisory Services first reported a position in ChemoCentryx, Inc. in Q4 2021 and held it in 2 quarters.
Level Four Advisory Services's ChemoCentryx, Inc. position peaked at $427K in Q4 2021.
182 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2022.

Based on Level Four Advisory Services's 13F filing for Q2 2022, filed 8 Aug 2022.